First Capital Advisors Group, Llc. Cara Therapeutics, Inc. Transaction History
First Capital Advisors Group, Llc.
- $188 Million
- Q2 2023
A detailed history of First Capital Advisors Group, Llc. transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, First Capital Advisors Group, Llc. holds 175 shares of CARA stock, worth $52. This represents 0.0% of its overall portfolio holdings.
Number of Shares
175Holding current value
$52% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CARA
# of Institutions
88Shares Held
16.5MCall Options Held
55KPut Options Held
500-
Vanguard Group Inc Valley Forge, PA2.25MShares$675,1000.0% of portfolio
-
Disciplined Growth Investors Inc Minneapolis, MN1.94MShares$580,7150.01% of portfolio
-
Chescapmanager LLC Baltimore, MD1.7MShares$510,6330.04% of portfolio
-
Farallon Capital Management LLC San Francisco, CA1.56MShares$466,8750.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.07MShares$319,7250.0% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $16.1M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...